Dengue Testing companies

  • Report ID: 3278
  • Published Date: Jul 14, 2025
  • Report Format: PDF, PPT

Key Dengue Testing Market Players:

    The dengue testing market is highly consolidated, with Roche, Abbott, and Siemens dominating 45.2% of the global financial outcome. These players are leveraging their capacity in localized manufacturing to reduce costs, integrating AI-driven automation to enhance accuracy, and forming Public-private alliances to expand worldwide territory. On the other hand, in emerging economies, pioneers are utilizing the surge in demand for affordable rapid tests, while Western firms are concentrating their focus on high-margin PCR/ELISA kits.

    The cohort of top contenders in this sector includes:

    Company Name

    Country

    Market Share (2024)

    Industry Focus

    Roche Diagnostics

    Switzerland

    18.1%

    PCR & ELISA tests; global leader in high-precision diagnostics

    Abbott Laboratories

    U.S.

    15.3%

    Rapid NS1 antigen tests & point-of-care solutions

    Siemens Healthineers

    Germany

    12.3%

    Automated lab systems & serology tests

    Thermo Fisher Scientific

    U.S.

    10.1%

    RT-PCR reagents & bulk test kit production

    Bio-Rad Laboratories

    U.S.

    8.4%

    ELISA kits & dengue antibody detection

    SD Biosensor

    South Korea

    xx%

    Low-cost rapid tests for emerging markets

    Quest Diagnostics

    U.S.

    xx%

    Lab-based testing services & outbreak surveillance

    Becton Dickinson (BD)

    U.S.

    xx%

    Portable diagnostic devices & microfluidic chips

    BioMérieux

    France

    xx%

    Multiplex assays for dengue & co-infections

    Ortho Clinical Diagnostics

    U.S.

    xx%

    Blood screening tests for transfusion safety

    Hologic

    U.S.

    xx%

    Molecular diagnostics & automated testing platforms

    PerkinElmer

    U.S.

    xx%

    Research-use-only (RUO) dengue reagents

    Trivitron Healthcare

    India

    xx%

    Affordable rapid tests for APAC & Africa

    J. Mitra & Co.

    India

    xx%

    Indigenous ELISA kits for public health programs

    CTK Biotech

    U.S.

    xx%

    Lateral flow rapid tests for decentralized settings

    InBios International

    U.S.

    xx%

    Antibody detection kits & outbreak response tools

    MP Biomedicals

    U.S.

    xx%

    Antigen capture tests & research reagents

    Atomo Diagnostics

    Australia

    xx%

    Compact, user-friendly rapid tests for remote areas

    Below are the areas covered for each company in the dengue testing market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the dengue testing market was over USD 780.4 million.

The market size for the dengue testing market is projected to reach USD 1.7 billion by the end of 2034, expanding at a CAGR of 7.1% during the forecast period, i.e., between 2025-2034.

The major players in the market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, and others.

In terms of test type, the NS1 antigen test segment is anticipated to garner the largest market share of 38.4% by 2034 and display lucrative growth opportunities during 2025-2034.

The market in Asia Pacific is projected to hold the largest market share of 45.2% by the end of 2034 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos